NEWTON, Mass.--(BUSINESS WIRE)--Cheetah Medical, a Massachusetts-based leader in non-invasive fluid management devices, today announced the first presentation of major economic data showing total cost ...

Sepsis is the body’s extreme reaction to an infection. It causes 11 million deaths annually and is a global health priority affecting 55 million patients worldwide annually. Treatment for sepsis ...

A multi-institutional research team has demonstrated how AI and machine learning can optimize therapy selection and dosing ...

Korea: Researchers have found in a new study that adjunctive dobutamine use did not improve short-term organ function or ...

Inotrem and Roche’s diagnostics division have upgraded their years-long collaboration on a plasma test for septic shock, with a new worldwide licensing agreement. The France-based Inotrem secured the ...

A long-awaited study of septic shock treatments has found that expensive and risky parts of a widely accepted resuscitation protocol now in place in many hospitals do not improve outcomes when ...

Sepsis, a common and potentially deadly complication to an infection, is the leading cause of death in U.S. hospitals, accounting for 35% of in-hospital deaths. But as many as 87% of sepsis cases ...

My 86-year-old father was recently hospitalized with a severe infection. We were told he’s at an increased risk for sepsis ...

According to a recent article in the American Journal of Respiratory and Clinical Care Medicine ICU stays, treatment duration, and hospital costs may be reduced if a blood test and a decision ...

SYDNEY--(BUSINESS WIRE)--Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) announced an international patent application aimed at protecting the use of experimental ...

USA TODAY reviewed in-custody death reports, revealing at least 1,780 sepsis-related deaths at prisons and jails nationally.

Craig Lilly, MD, a pulmonary medicine and critical care specialist at the University of Massachusetts Memorial Medical Center, who was not one of the trial results authors, reacted to the study. "This ...